[ad_1]
9:00 AM
ALERT :: Sun Pharma enters into a non-exclusive patent licensing agreement with Takeda Pharmaceutical
Sun Pharma and includes its subsidiaries and/or associate companies) today announced that it has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialise Vonoprazan tablets 10 mg, 20 mg in India under the brand name “Voltapraz”.
Vonoprazan is a novel, orally active potassium competitive acid blocker (PCAB), used to treat reflux esophagitis and other acid peptic disorders.
Under the terms of this agreement, Takeda has granted Sun Pharma non-exclusive patent licensing rights for the commercialization of Vonoprazan in India.
8:55 AM
Budget 2024-25: New income tax regime may offer a treat to salaried class
Amid the Budget preparation, the revenue department is assessing the feasibility of further adjustments to maximise benefits for salaried individuals. “Gradually transitioning to a predictable tax regime with minimal rates and phasing out deductions and exemptions have always been the intention, and will be a central focus in the review process, which could potentially include changes in tax rates,” an official familiar with discussions on the matter told Business Standard. READ MORE
8:50 AM
Sebi tightens norms for IPO price discovery to curb manipulation
In certain cases of IPOs and relisted scrips, the market regulator observed that though orders were being placed at higher price in large volumes during the call auction, a significant portion of these orders were cancelled just before the session closed. This led to false demand and supply, leading to possible manipulation of prices of the scrips. READ MORE
8:45 AM
Gold zooms to two-week high on rate cut speculation; trading strategy here
On Thursday, three major central banks came out with their monetary policies. The Swiss National Bank lowered borrowing costs at a second straight meeting in a somewhat unexpected move. The Central Bank slashed the key rate by 25 bps to 1.25 per cent. READ MORE
8:41 AM
Silver strategy: White metal may rise to Rs 93,400; Support at Rs 90,300
The markets are currently pricing in a probability of 65 per cent for a rate cut in September as traders look for more than one rate cut this year. However, it is worth noting that the markets’ rate cut outlook is somewhat at odds with the Federal Reserve that projected just one rate cut in its recently concluded FOMC meeting. Slowing pace of green energy transition and a possibility of a measured rise in gold prices in near term may also limit the upside in silver. READ MORE
[ad_2]
Source link